Literature DB >> 1942772

Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients.

T Bertani1, P Ferrazzi, A Schieppati, P Ruggenenti, A Gamba, L Parenzan, G Mecca, N Perico, O Imberti, A Remuzzi.   

Abstract

We sought to clarify whether low-dose cyclosporine (5.0 +/- 2.2 mg/kg/day) given for more than two years to prevent cardiac graft rejection induced glomerular injury and to quantify the extent of the lesions. After renal hemodynamic studies, renal biopsy specimens were obtained from 10 patients on cyclosporine and analyzed by a novel morphometric technique consisting of a tridimensional reconstruction of the glomerular tuft. Autopsy kidney specimens from three patients with no clinical history of renal disease, and from four patients who died with dilatative cardiomyopathy served as controls. The glomerular filtration rate and renal plasma flow were significantly depressed below normal values in transplant recipients given cyclosporine, averaging 35 +/- 8 and 325 +/- 94 ml/min/1.73 m2, respectively. Conventional light microscopy of specimens from controls and from patients who died with dilatative cardiomyopathy did not reveal renal structural abnormalities. By contrast kidney specimens from cyclosporine-treated patients had obliterative arteriolopathy and ischemic-type changes, with thickening and wrinkling of glomerular capillary wall. Morphometrical analysis of 28 control glomeruli and 40 glomeruli from patients with dilatative cardiomyopathy showed glomerular capillary tuft volumes (VCT) ranging between 1.2 and 2.3 microns 3 x 10(-6), whereas of 102 glomeruli from cyclosporine-treated patients 42.1% had VCT lower than 1.2 microns 3 x 10(-6) and 24.4% VCT higher than 2.3 microns 3 x 10(-6).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942772     DOI: 10.1038/ki.1991.206

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Byung Ha Chung; Bo-Mi Kim; Mi-La Cho; Chul Woo Yang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 3.  Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

Review 4.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

5.  Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF-beta 1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells.

Authors:  S Di Paolo; G Grandaliano; L Gesualdo; E Ranieri; F P Schena
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 6.  Chronic renal insufficiency in heart transplant recipients: risk factors and management options.

Authors:  Francisco González-Vílchez; José Antonio Vázquez de Prada
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 7.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

8.  Glomerular tip changes in childhood minimal change nephropathy.

Authors:  Alexander J Howie; Anju Agarwal; Neil J Sebire; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

9.  Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A.

Authors:  Wei-Sheng Chen; An-Hang Young; Hon-Pin Wang; De-Feng Huang
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

10.  Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats.

Authors:  Ji Hong Kim; Yeon Hee Lee; Beom Jin Lim; Hyeon Joo Jeong; Pyung Kil Kim; Jae Il Shin
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.